Joao Gorgulho

Affiliations

II. Department of Medicine

1 - 8 out of 8Page size: 50

Sort by: Publication date

Publications

2023
Peripheral blood CD3+HLADR+ cells and associated gut microbiome species predict response and overall survival to immune checkpoint blockade
Gorgulho, J., Roderburg, C., Beier, F., Bokemeyer, C., Brümmendorf, T., Luedde, T. & Loosen, S. H., 29.08.2023, In: FRONT IMMUNOL. 14, p. 1206953 1206953.
Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
2021
Serum levels of soluble B and T lymphocyte attenuator predict overall survival in patients undergoing immune checkpoint inhibitor therapy for solid malignancies
Gorgulho, J., Roderburg, C., Heymann, F., Schulze-Hagen, M., Beier, F., Vucur, M., Kather, J. N., Laleh, N. G., Tacke, F., Brümmendorf, T. H., Luedde, T. & Loosen, S. H., 01.09.2021, In: INT J CANCER. 149, 5, p. 1189-1198 10 p.
Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Macrophage migration inhibitory factor predicts an unfavorable outcome after transarterial chemoembolization for hepatic malignancies
Wirtz, T. H., Loosen, S. H., Schulze-Hagen, M., Gorgulho, J., Kandler, J., Joerdens, M., Demir, M., Mohr, R., Bruners, P., Kuhl, C., Trautwein, C., Berres, M-L., Tacke, F., Luedde, T. & Roderburg, C., 09.2021, In: CTS-CLIN TRANSL SCI. 14, 5, p. 1853-1863 11 p.
Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Telomere Shortening in Peripheral Leukocytes Is Associated With Poor Survival in Cancer Patients Treated With Immune Checkpoint Inhibitor Therapy
Rolles, B., Gorgulho, J., Tometten, M., Roderburg, C., Vieri, M., Abels, A., Vucur, M., Heymann, F., Tacke, F., Brümmendorf, T. H., Luedde, T., Beier, F. & Loosen, S. H., 19.08.2021, In: FRONT ONCOL. 11, p. 729207
Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Serum Levels of Soluble Urokinase Plasminogen Activator Receptor Predict Tumor Response and Outcome to Immune Checkpoint Inhibitor Therapy
Loosen, S. H., Gorgulho, J., Jördens, M. S., Schulze-Hagen, M., Beier, F., Vucur, M., Schneider, A. T., Koppe, C., Mertens, A., Kather, J. N., Tacke, F., Keitel, V., Brümmendorf, T. H., Roderburg, C. & Luedde, T., 01.04.2021, In: FRONT ONCOL. 11, p. 646883
Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Progressive Sarcopenia Correlates with Poor Response and Outcome to Immune Checkpoint Inhibitor Therapy
Loosen, S. H., van den Bosch, V., Gorgulho, J., Schulze-Hagen, M., Kandler, J., Jördens, M. S., Tacke, F., Loberg, C., Antoch, G., Brümmendorf, T., Neumann, U. P., Kuhl, C., Luedde, T. & Roderburg, C., 25.03.2021, In: J CLIN MED. 10, 7, 1361.
Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Elevated soluble urokinase plasminogen activator receptor serum levels indicate poor survival following transarterial chemoembolization therapy for hepatic malignancies: An exploratory analysis
Loosen, S. H., Schulze-Hagen, M., Vucur, M., Gorgulho, J., Paffenholz, P., Benz, F., Mohr, R., Demir, M., Wree, A., Kuhl, C., Trautwein, C., Tacke, F., Bruners, P., Luedde, T. & Roderburg, C., 03.2021, In: JGH OPEN. 5, 3, p. 356-363 8 p.
Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
2020
Circulating levels of soluble urokinase plasminogen activator receptor predict outcome after resection of biliary tract cancer
Loosen, S. H., Breuer, A., Tacke, F., Kather, J. N., Gorgulho, J., Alizai, P. H., Bednarsch, J., Roeth, A. A., Lurje, G., Schmitz, S. M., Brozat, J. F., Paffenholz, P., Vucur, M., Ritz, T., Koch, A., Trautwein, C., Ulmer, T. F., Roderburg, C., Longerich, T., Neumann, U. P. & Luedde, T., 04.2020, In: JHEP REP. 2, 2, 100080.
Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review